These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21503833)

  • 1. Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatment.
    Gonzalez JS; Psaros C; Batchelder A; Applebaum A; Newville H; Safren SA
    Ann Behav Med; 2011 Aug; 42(1):120-6. PubMed ID: 21503833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.
    Gonzalez A; Mimiaga MJ; Israel J; Andres Bedoya C; Safren SA
    AIDS Behav; 2013 Jan; 17(1):168-73. PubMed ID: 23008124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.
    Berg KM; Litwin A; Li X; Heo M; Arnsten JH
    Drug Alcohol Depend; 2011 Jan; 113(2-3):192-9. PubMed ID: 20832196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance.
    Newville H; Berg KM; Gonzalez JS
    Int J Behav Med; 2015 Apr; 22(2):214-22. PubMed ID: 25081100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial.
    Safren SA; O'Cleirigh CM; Bullis JR; Otto MW; Stein MD; Pollack MH
    J Consult Clin Psychol; 2012 Jun; 80(3):404-15. PubMed ID: 22545737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.
    Dale S; Cohen M; Weber K; Cruise R; Kelso G; Brody L
    AIDS Patient Care STDS; 2014 Mar; 28(3):136-43. PubMed ID: 24568654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitigating the risk of HIV infection with opioid substitution treatment.
    Gowing LR; Hickman M; Degenhardt L
    Bull World Health Organ; 2013 Feb; 91(2):148-9. PubMed ID: 23554530
    [No Abstract]   [Full Text] [Related]  

  • 8. "Damaging what wasn't damaged already": psychological tension and antiretroviral adherence among HIV-infected methadone-maintained drug users.
    Batchelder AW; Brisbane M; Litwin AH; Nahvi S; Berg KM; Arnsten JH
    AIDS Care; 2013; 25(11):1370-4. PubMed ID: 23406479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the association between Addiction Severity Index and depression with adherence to anti-retroviral therapy among HIV infected patients.
    Paydary K; Ekhtiari H; Noori M; Rad MV; Hajiabdolbaghi M; SeyedAlinaghi S
    Infect Disord Drug Targets; 2015; 15(3):177-83. PubMed ID: 26411558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
    Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
    Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to Antiretroviral Therapy Among Incarcerated Persons with HIV: Associations with Methadone and Perceived Safety.
    Culbert GJ; Waluyo A; Wang M; Putri TA; Bazazi AR; Altice FL
    AIDS Behav; 2019 Aug; 23(8):2048-2058. PubMed ID: 30465106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).
    Shrestha R; Copenhaver MM
    Addict Behav; 2018 Oct; 85():88-93. PubMed ID: 29879611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A closer look at depression and its relationship to HIV antiretroviral adherence.
    Wagner GJ; Goggin K; Remien RH; Rosen MI; Simoni J; Bangsberg DR; Liu H;
    Ann Behav Med; 2011 Dec; 42(3):352-60. PubMed ID: 21818528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression, substance abuse and other contextual predictors of adherence to antiretroviral therapy (ART) among Haitians.
    Malow R; Dévieux JG; Stein JA; Rosenberg R; Jean-Gilles M; Attonito J; Koenig SP; Raviola G; Sévère P; Pape JW
    AIDS Behav; 2013 May; 17(4):1221-30. PubMed ID: 23338563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.
    Applebaum AJ; Reilly LC; Gonzalez JS; Richardson MA; Leveroni CL; Safren SA
    AIDS Patient Care STDS; 2009 Jun; 23(6):455-62. PubMed ID: 19519229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine.
    Mimiaga MJ; Safren SA; Dvoryak S; Reisner SL; Needle R; Woody G
    AIDS Care; 2010 Nov; 22(11):1305-13. PubMed ID: 20640954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.
    Safren SA; Bedoya CA; O'Cleirigh C; Biello KB; Pinkston MM; Stein MD; Traeger L; Kojic E; Robbins GK; Lerner JA; Herman DS; Mimiaga MJ; Mayer KH
    Lancet HIV; 2016 Nov; 3(11):e529-e538. PubMed ID: 27658881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence Among HIV-Positive Methadone-Maintained Patients.
    Shrestha R; Altice FL; Copenhaver MM
    J Acquir Immune Defic Syndr; 2019 Feb; 80(2):166-173. PubMed ID: 30383588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonadherence among HIV-infected injecting drug users: the impact of social instability.
    Bouhnik AD; Chesney M; Carrieri P; Gallais H; Moreau J; Moatti JP; Obadia Y; Spire B;
    J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S149-53. PubMed ID: 12562040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.